Symbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...

Aragen Life Sciences has filed its DRHP with Sebi for an IPO comprising a Rs 800 crore fresh issue and an OFS. Proceeds will fund debt repa...

Given the possibility of hostilities resuming in the Gulf region, focus on risk management in the market. Why? Because fresh hostilities wi...

In an interaction with Kshitij Anand of ETMarkets, Saurabh Prasad, Head – Research Centre at Mirae Asset Sharekhan, said large caps are now...

Sharma sees a stronger case for large caps over the next 24 months, particularly given the steep valuation premium commanded by small caps.

Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...

Jefferies has initiated coverage on Anthem Biosciences with a Buy rating and Rs 1,050 target, implying around 20% upside. The brokerage is ...

Despite muted foreign flows and persistent geopolitical uncertainties keeping a lid on the broader market, corporate earnings have remained...

Here’s one thing to watch for in the next few weeks: How does the street treat disappointments in the mid-cap segment? If the reaction is l...

Tube Investments of India shares surged after the company reported a 5% year-on-year decline in Q1FY27 profit to Rs 158.62 crore, despite a...

What is volatility? There is, of course, a mathematical definition. Then there is the human definition, which is how investors feel it. In ...

Shares of Zydus Lifesciences saw a decline of more than two percent following the announcement of a notable profit drop. The net profit plu...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

A word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...

Motilal Oswal Private Wealth favors Indian mid and small-cap stocks. They are increasing allocations to these segments by ten percentage po...

Ace investor Ashish Kacholia has reduced holdings in two chemical stocks. Yasho Industries and Fineotex Chemicals saw stake reductions by t...

Mirae Asset Investment Managers (India)’s equity funds have experienced a period of underperformance—the first major blip since inception i...